文献速递其他结缔组织病

新多效性位点揭示系统性硬化症与原发性雷诺现象的血管与免疫通路关联

Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本研究基于全基因组关联研究(GWAS)汇总数据,对原发性雷诺现象(4 986例病例和850 981例对照)与系统性硬化症(10 654例病例和18 043例对照)进行跨性状荟萃分析(约8.6M个单核苷酸多态性),识别出五个新的多效性位点,并构建多基因风险评分(PRS)。PRS模型区分度 modest(AUC=0.57),但可识别原发性雷诺现象个体中具有高遗传风险发展为系统性硬化症者(75th百分位,相对风险=1.29 [95% CI 1.02, 1.62];P值=3.58 × 10-2)。研究揭示了原发性雷诺现象与系统性硬化症之间的遗传联系,支持遗传分析用于早期风险评估和个性化监测的潜力。

要点

  • 发现五个新的多效性位点,包括MEOX2(对两性状效应相反)、ADRA2A(系统性硬化症新位点)、IL12A、NFKB1和TNIP1(原发性雷诺现象新位点)。
  • PRS模型区分度 modest(AUC=0.57),但可识别原发性雷诺现象个体中高遗传风险发展为系统性硬化症者(75th百分位,相对风险=1.29 [95% CI 1.02, 1.62];P值=3.58 × 10-2)。
  • 功能注释突出血管和炎症通路,支持原发性雷诺现象与系统性硬化症共享遗传结构。

核心结论

  • 本研究揭示了原发性雷诺现象与系统性硬化症之间的遗传联系,识别出五个新的多效性位点,并支持遗传分析用于早期风险评估和个性化监测策略的潜力。

研究设计与样本

  • 研究分析了原发性雷诺现象(4 986例病例和850 981例对照)和系统性硬化症(10 654例病例和18 043例对照)的全基因组关联研究(GWAS)汇总数据,进行了跨性状荟萃分析(约8.6M个单核苷酸多态性),并构建了多基因风险评分(PRS)。

主要发现

  • 除已知的HLA关联外,识别出五个额外的多效性位点,包括MEOX2(对两性状效应相反的新关联)、ADRA2A(系统性硬化症的新遗传因素)、IL12A、NFKB1和TNIP1(原发性雷诺现象的新位点)。
  • 功能注释突出了血管和炎症通路。
  • PRS模型显示 modest 区分度(AUC=0.57),但可识别原发性雷诺现象个体中具有高遗传风险发展为系统性硬化症者(75th百分位,相对风险=1.29 [95% CI 1.02, 1.62];P值=3.58 × 10-2)。

关键数值与推荐

  • PRS模型区分度:AUC=0.57。
  • 高遗传风险识别:75th百分位,相对风险=1.29 [95% CI 1.02, 1.62];P值=3.58 × 10-2。

临床怎么用

  • 遗传分析可能有助于原发性雷诺现象患者的早期风险评估,识别具有高遗传风险发展为系统性硬化症的个体,从而支持个性化监测策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Raynaud's phenomenon (RP) is the first noticeable symptom of systemic sclerosis (SSc), appearing even years before other signs. Vascular and immune pathways, hallmarks in SSc pathogenesis, are implicated in primary RP. Hence, we aimed to define the shared genetic architecture between these conditions to explore pathogenic mechanisms and whether pleiotropic loci could help identify primary RP patients at increased genetic risk of developing SSc. METHODS: We analysed genome-wide association study (GWAS) summary statistics for primary RP (4 986 cases and 850 981 controls) and SSc (10 654 cases and 18 043 controls). We performed a cross-trait meta-analysis (∼8.6M single nucleotide polymorphisms) to identify variants associated with both diseases. Functional annotation was used to prioritise potential causal genes. We also constructed a polygenic risk score (PRS) to assess clinical implications. RESULTS: Beyond the well-known HLA associations, we identified five additional pleiotropic loci, including MEOX2 as a novel association for both traits with opposing effects, ADRA2A representing a novel genetic factor for SSc, and IL12A, NFKB1 and TNIP1 as novel loci for primary RP. Functional annotation highlighted vascular and inflammatory pathways. Finally, the PRS model shows modest discrimination (area under the curve = 0.57). However, it allows the identification of primary RP individuals at high genetic risk of developing SSc (75th percentile, relative risk =1.29 [95% CI 1.02, 1.62]; P-value= 3.58 × 10-2). CONCLUSION: This study reveals a genetic link between primary RP and SSc, identifying five novel pleiotropic loci and supporting the potential of genetic profiling for early risk assessment and personalised monitoring strategies.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Rangel-Peláez C, Rodriguez-Martin I, Rosa-Baez C, et al. Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon. Rheumatology (Oxford). 2026. PMID: 41965070. doi:10.1093/rheumatology/keag164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。